Dr MUTTER Catherine

Fiche personne

Coordonnées

Centre d’Investigation Clinique Plurithématique (CIC-P)
Nouvel Hôpital Civil
1 place de l’Hôpital
67091 STRASBOURG Cedex

03 69 55 13 63

Territoire

Alsace

Statut

Hospitalier

Affiliation

Hôpitaux universitaires de Strasbourg (CHRU Strasbourg)

Équipes/plateformes

Equipe Inserm CIC-P 1434 (Centre d'Investigation Clinique Plurithématique)

Recherche

Expertises :
- Clinique:Recherche clinique

Projets

Étude de phase II, randomisée, en double aveugle, contrôlée versus placebo, pour évaluer l’efficacité et la sécurité de l’allopregnanolone chez des sujets atteints de cancer colorectal développant une neuropathie périphérique induite par l’oxaliplatine

2016 - Porteur du projet : Dr MUTTER Catherine

Publications

Dementia with Lewy bodies and gait neural basis: a cross-sectional study.

Sainsily-Cesarus A, Schmitt E, Landre L, Botzung A, Rauch L, Demuynck C, Philippi N, de Sousa PL, Mutter C, Cretin B, Martin-Hunyadi C, Blanc F

Alzheimers Res Ther. 2024 07 30;16(1):170

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.

Gorochov G, Ropers J, Launay O, Dorgham K, da Mata-Jardin O, Lebbah S, Durier C, Bauer R, Radenne A, Desaint C, Vieillard LV, Rekacewicz C, Lachatre M, Parfait B, Batteux F, Hupé P, Ninove L, Lefebvre M, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian JJ, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Botelho-Nevers E, Lelièvre JD, de Lamballerie X, Kieny MP, Tartour E, Paul S

JAMA Netw Open. 2024 04 1;7(4):e248051

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.

Durier C, Ninove L, van der Werf S, Lefebvre M, Desaint C, Bauer R, Attia M, Lecompte AS, Lachatre M, Maakaroun-Vermesse Z, Nicolas JF, Verdon R, Kiladjian JJ, Loubet P, Schmidt-Mutter C, Corbin V, Ansart S, Melica G, Resch M, Netzer E, Kherabi Y, Tardieu R, Lelièvre JD, Tartour E, Meyer L, de Lamballerie X, Launay O,

Infect Dis Now. 2024 03 15;:104886

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.

Puri A, Pollard AJ, Schmidt-Mutter C, Lainé F, PrayGod G, Kibuuka H, Barry H, Nicolas JF, Lelièvre JD, Sirima SB, Kamala B, Manno D, Watson-Jones D, Gaddah A, Keshinro B, Luhn K, Robinson C, Douoguih M,

Vaccines (Basel). 2024 02 17;12(2):

Dopamine precursor depletion affects performance and confidence judgements when events are timed from an explicit, but not an implicit onset.

Jovanovic L, Chassignolle M, Schmidt-Mutter C, Behr G, Coull JT, Giersch A

Sci Rep. 2023 12 11;13(1):21933

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O, ,,,,,,

Sci Rep. 2022 11 27;12(1):20373

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.

Launay O, Cachanado M, Luong Nguyen LB, Ninove L, Lachâtre M, Ben Ghezala I, Bardou M, Schmidt-Mutter C, Lacombe K, Laine F, Allain JS, Botelho-Nevers E, Tavolacci MP, Chidiac C, Pavese P, Dussol B, Priet S, Deplanque D, Touati A, Curci L, Konate E, Ben Hamouda N, Besbes A, Nubret E, Capelle F, Berard L, Rousseau A, Tartour E, Simon T, de Lamballerie X

N Engl J Med. 2022 06 29;:

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.

Janssen C, Cachanado M, Ninove L, Lachatre M, Michon J, Epaulard O, Maakaroun-Vermesse Z, Chidiac C, Laviolle B, Aumaitre H, Assaf A, Lacombe K, Schmidt-Mutter C, Botelho-Nevers E, Briere M, Boisson T, Loubet P, Bienvenu B, Bouchaud O, Touati A, Pereira C, Rousseau A, Berard L, Montil M, de Lamballerie X, Simon T, Launay O,

EClinicalMedicine. 2022 06;48:101444

Safety and antiviral activity of EGFR inhibition by erlotinib in chronic hepatitis C patients: a phase Ib randomized controlled trial.

Saviano A, Habersetzer F, Lupberger J, Simo-Noumbissie P, Schuster C, Doffoël M, Schmidt-Mutter C, Baumert TF

Clin Transl Gastroenterol. 2022 Apr 1;:

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S

Infect Dis Now. 2021 Nov 11;:

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S

EBioMedicine. 2021 Aug 26;71:103561

Dopamine Precursor Depletion in Healthy Volunteers Impairs Processing of Duration but Not Temporal Order.

Chassignolle M, Jovanovic L, Schmidt-Mutter C, Behr G, Giersch A, Coull JT

J Cogn Neurosci. 2021 Apr 1;33(5):946-963

Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.

Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Séze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S

J Infect Dis. 2021 Mar 7;:

Dopamine Precursor Depletion in Healthy Volunteers Impairs Processing of Duration but Not Temporal Order.

Chassignolle M, Jovanovic L, Schmidt-Mutter C, Behr G, Giersch A, Coull JT

J Cogn Neurosci. 2021 Mar 3;:1-18

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.

Velay A, Gallais F, Benotmane I, Wendling MJ, Danion F, Collange O, De Sèze J, Schmidt-Mutter C, Schneider F, Bilbault P, Meziani F, Fafi-Kremer S

Diagn. Microbiol. Infect. Dis.. 2020 Aug 21;98(4):115181

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, Bolle A, Velay A, Lefebvre N, Mielcarek M, Meyer N, Rey D, Charneau P, Hoen B, De Seze J, Schwartz O, Fontanet A

EBioMedicine. 2020 Jul 31;:102915

Influence of psychological stress on non-surgical periodontal treatment outcomes in severe chronic periodontitis patients.

Petit C, Anadon-Rosinach V, Rettig L, Schmidt-Mutter C, Tuzin N, Davideau JL, Huck O

J. Periodontol.. 2020 Jul 27;:

Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer's disease and normal aging: implications for fluctuations.

Chabran E, Noblet V, Loureiro de Sousa P, Demuynck C, Philippi N, Mutter C, Anthony P, Martin-Hunyadi C, Cretin B, Blanc F

Alzheimers Res Ther. 2020 Jan 6;12(1):9

Baropodometric quantification and implications of muscle coactivation in the lower limbs caused by head movement: A prospective study.

Nisand M, Callens C, Destieux C, Dyer JO, Chanson JB, Sauleau E, Mutter C

J Bodyw Mov Ther. 2020 Jan;24(1):228-234

Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.

Detoc M, Launay O, Dualé C, Mutter C, Le Huec JC, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E

Vaccine. 2019 Sep 19;:

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr MUTTER Catherine

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Projets

Étude de phase II, randomisée, en double aveugle, contrôlée versus placebo, pour évaluer l’efficacité et la sécurité de l’allopregnanolone chez des sujets atteints de cancer colorectal développant une neuropathie périphérique induite par l’oxaliplatine

Publications

Dementia with Lewy bodies and gait neural basis: a cross-sectional study.

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.

Dopamine precursor depletion affects performance and confidence judgements when events are timed from an explicit, but not an implicit onset.

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.

Safety and antiviral activity of EGFR inhibition by erlotinib in chronic hepatitis C patients: a phase Ib randomized controlled trial.

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

Dopamine Precursor Depletion in Healthy Volunteers Impairs Processing of Duration but Not Temporal Order.

Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.

Dopamine Precursor Depletion in Healthy Volunteers Impairs Processing of Duration but Not Temporal Order.

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Influence of psychological stress on non-surgical periodontal treatment outcomes in severe chronic periodontitis patients.

Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer's disease and normal aging: implications for fluctuations.

Baropodometric quantification and implications of muscle coactivation in the lower limbs caused by head movement: A prospective study.

Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.

Increased expression of blood muscarinic receptors in patients with reflex syncope.

Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy.

Cognitive profile in prodromal dementia with Lewy bodies.

Retrouvez aussi